TAKEDA PHARMACEUTICAL CO LTD
TAK
52 insider filings · Latest: Sep 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 13 1:23 AM | Natalie Anne Marie FurneyGlobal General Counsel | Sale | 30,868 | $17.10 | $527.8K | 204,298(D) | View → |
| Aug 11, 2026 | Aug 12 8:10 PM | Elaine Mary ShannonPres., Global Supply & Quality | Sale | 20,363 | $17.55 | $357.4K | 67,311(D) | View → |
| Aug 10, 2026 | Aug 12 8:10 PM | Nicola Deidre Petal GreenwayChief Human Resources Officer | Sale | 34,603 | $17.51 | $605.8K | 59,803(D) | View → |
| Aug 11, 2026 | Aug 10 8:30 PM | Elaine Shannon | Proposed Sale | 20,363 | $17.45 | $355.3K | — | View → |
| Aug 7, 2026 | Aug 6 9:17 PM | Nicola Greenway | Proposed Sale | 34,603 | $16.72 | $578.6K | — | View → |
| Jul 13, 2026 | Jul 13 10:26 AM | Marcello Pignagnoli Agosti | Proposed Sale | 24,887 | $16.75 | $416.9K | — | View → |
| Jul 13, 2026 | Jul 13 10:26 AM | Lauren Rusckowski Duprey | Proposed Sale | 51,579 | $16.75 | $863.9K | — | View → |
| Jul 13, 2026 | Jul 13 10:25 AM | Giles Platford | Proposed Sale | 33,696 | $16.75 | $564.4K | — | View → |
| Jul 13, 2026 | Jul 13 10:25 AM | Natalie Furney | Proposed Sale | 33,454 | $16.75 | $560.4K | — | View → |
| Jul 13, 2026 | Jul 13 10:24 AM | Gabriele Ricci | Proposed Sale | 27,197 | $16.75 | $455.5K | — | View → |
| Jul 13, 2026 | Jul 13 10:24 AM | Nicola Greenway | Proposed Sale | 7,348 | $16.75 | $123.1K | — | View → |
| Jul 13, 2026 | Jul 13 10:23 AM | Elaine Shannon | Proposed Sale | 4,319 | $16.75 | $72.4K | — | View → |
| Jul 13, 2026 | Jul 13 10:23 AM | Ramy Riad | Proposed Sale | 7,889 | $16.75 | $132.1K | — | View → |
| Jul 13, 2026 | Jul 13 10:22 AM | Awny Farajallah | Proposed Sale | 15,188 | $16.75 | $254.4K | — | View → |
| Jul 13, 2026 | Jul 13 10:22 AM | Rhonda Pacheco | Proposed Sale | 18,316 | $16.75 | $306.8K | — | View → |
| Jul 13, 2026 | Jul 13 10:21 AM | Andrew Plump | Proposed Sale | 179,239 | $16.75 | $3.0M | — | View → |
| Jul 13, 2026 | Jul 13 10:21 AM | Teresa Bitetti | Proposed Sale | 54,210 | $16.75 | $908.0K | — | View → |
| Jul 13, 2026 | Jul 13 10:07 AM | Julie Kim | Proposed Sale | 96,558 | $16.75 | $1.6M | — | View → |
| Dec 9, 2025 | Dec 9 11:05 AM | Lauren Rusckowski Duprey | Proposed Sale | 29,619 | $14.22 | $421.2K | — | View → |
| Dec 5, 2025 | Dec 5 11:08 AM | Teresa Marie Bitetti | Proposed Sale | 87,023 | $14.28 | $1.2M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 6 10:29 PM | Steven GillisDirector | Disposition | 1,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:29 PM | Steven GillisDirector | Grant/Award | 1,319 | — | 1,319(D) | View → |
| Jul 10, 2026 | Jul 6 10:28 PM | John MaraganoreDirector | Disposition | 1,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:28 PM | John MaraganoreDirector | Grant/Award | 1,319 | — | 1,319(D) | View → |
| Jul 10, 2026 | Jul 6 10:28 PM | Kimberly A. ReedDirector | Disposition | 1,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:28 PM | Kimberly A. ReedDirector | Grant/Award | 1,319 | — | 1,319(D) | View → |
| Jul 10, 2026 | Jul 6 10:14 PM | Masami IijimaDirector | Disposition | 2,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:14 PM | Masami IijimaDirector | Grant/Award | 1,937 | — | 1,937(D) | View → |
| Jul 1, 2026 | Jul 6 10:12 PM | Bruce D BroussardDirector | Grant/Award | 1,319 | — | 1,319(D) | View → |
| Jul 1, 2026 | Jul 6 10:11 PM | Paulus StoffelsDirector | Grant/Award | 1,307 | — | 1,307(D) | View → |
| Jul 1, 2026 | Jul 6 10:10 PM | Koichiro KimuraDirector | Grant/Award | 1,937 | — | 1,937(D) | View → |
| Jul 10, 2026 | Jul 6 10:10 PM | Miki TsusakaDirector | Disposition | 2,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:10 PM | Miki TsusakaDirector | Grant/Award | 1,937 | — | 1,937(D) | View → |
| Jul 10, 2026 | Jul 6 10:09 PM | Asuka MiyabashiraPresident, Japan Pharma B.U. | Disposition | 1,022 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:09 PM | Asuka MiyabashiraPresident, Japan Pharma B.U. | Grant/Award | 1,994 | — | 666(D) | View → |
| Jul 10, 2026 | Jul 6 10:09 PM | Milano FurutaDirector, Chief Financial Officer | Disposition | 16,619 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:09 PM | Milano FurutaDirector, Chief Financial Officer | Grant/Award | 12,864 | — | 4,288(D) | View → |
| Jul 1, 2026 | Jul 6 10:02 PM | Julie So-Young KimDirector, President and CEO | Grant/Award | 23,225 | — | 7,743(D) | View → |
| Apr 27, 2026 | Apr 28 10:08 AM | Christophe Pierre WeberDirector, President and CEO | Grant/Award | 78,978 | — | 125,345(D) | View → |
| Apr 27, 2026 | Apr 28 10:08 AM | Milano FurutaDirector, Chief Financial Officer | Grant/Award | 7,814 | — | 16,619(D) | View → |